Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.

Huang W, Zhang X, Wang Z, ZhangBao J, Zhou L, Li X, Tan H, Dong Q, Quan C

J Neurol Neurosurg Psychiatry. 2026 Sep 15. PMID: 42744600. Abstract